Induction of Telomerase Catalytic Subunit Alternative Splicing by Apoptotic Endonuclease G in Mouse and Rat Lymphocytes

It is known that apoptotic endonuclease G (EndoG) induces alternative splicing (AS) of telomerase catalytic subunit TERT (telomerase reverse transcriptase) mRNA and inhibits telomerase activity in tumor cells and activated human T cells. The aim of this study was to investigate the possibility of TERT mRNA AS induction and inhibition of telomerase activity by EndoG in activated mouse and rat lymphocytes. To induce EndoG expression, mouse and rat CD4+, CD8+ T cells, B cells, and NK cells were transfected with the pEndoG-GFP plasmid or incubated with the DNA-damaging agent cisplatin in vitro. The increase in the EndoG expression resulted in decreased expression of full-length active TERT variant, enhanced synthesis of the truncated splicing variant, and decreased telomerase activity. An increase in the EndoG expression, a change in the mRNA pool of TERT splicing variants, and inhibition of telomerase activity were observed in mouse and rat lymphocytes after cisplatin administration in vivo. Thus, EndoG is capable of inducing TERT mRNA AS and regulating telomerase activity in mouse and rat lymphocytes. © 2018, Pleiades Publishing, Ltd.

Authors
Zhdanov D.D. 1 , Gladilina Y.A.1 , Orlova V.S. 2 , Grishin D.V.1 , Pokrovskaya M.V.1 , Aleksandrova S.S.1 , Podobed O.V.1 , Sokolov N.N.1
Number of issue
3
Language
English
Pages
217-230
Status
Published
Volume
12
Year
2018
Organizations
  • 1 Orekhovich Institute of Biomedical Chemistry, Moscow, 119121, Russian Federation
  • 2 Peoples’ Friendship University of Russia, Moscow, 117198, Russian Federation
Keywords
alternative splicing; apoptotic endonuclease; lymphocytes; telomerase
Date of creation
19.10.2018
Date of change
19.10.2018
Short link
https://repository.rudn.ru/en/records/article/record/6666/
Share

Other records